Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy

Background: Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus. It has been suggested that nitric oxide (NO) and α2β1 integrin (a platelet receptor for collagen) play an imp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Application of clinical genetics 2012-07, Vol.5, p.55
Hauptverfasser: Ellakwa, Amin Faisal, Azmy Elshazly, Dawood, Abdelraouf, Kelany Abdelhameed, Abdelsatar Elghobashy, Eldaly, mohammed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 55
container_title Application of clinical genetics
container_volume 5
creator Ellakwa, Amin Faisal
Azmy Elshazly
Dawood, Abdelraouf
Kelany Abdelhameed
Abdelsatar Elghobashy
Eldaly, mohammed
description Background: Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus. It has been suggested that nitric oxide (NO) and α2β1 integrin (a platelet receptor for collagen) play an important role in the pathogenesis of microvascular complications in DR. Aim: The aim of this study was to investigate the association of two candidate genes involved in the regulation of retinal vasculature, endothelial nitric oxide synthase (eNOS) and α2β1 integrin (ITGA2) genes, with the development of DR in Egyptian patients with type 2 diabetes mellitus and to investigate whether genetic variants will affect the type of retinopathy (proliferative or nonproliferative). Methods: In this study, 70 patients were enrolled and categorized into two groups: (1) a DR group consisting of 50 patients with DR, which was further subclassified into 25 patients with nonproliferative DR (NPDR group) and 25 patients with proliferative DR (PDR group) and (2) a diabetes without retinopathy (DWR) group, comprising 20 patients with type 2 diabetes of more than 10 years' duration who showed no signs of DR. Associations of the genetic polymorphisms of eNOS (G894T) and ITGA2 (BgI II) were studied. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed for all samples to evaluate the genotypes and correlate with the phenotype of the disease. Results: The allele frequencies of both polymorphisms showed considerable differences between patients with and without DR. The GG genotype of G894T polymorphism of eNOS was associated with a 9.75-fold increased risk of DR (95% confidence interval 1.7–55.4) and the genotype ITGA2 BgI II (+/+) was associated with a 10.1-fold increased risk of DR (95% confidence interval 1.8–57.9), while the α2β1 integrin gene polymorphism of genotype distribution of both eNOS and ITGA2 polymorphisms did not differ significantly between the proliferative and nonproliferative DR groups. Conclusion: A significant association between the G894T polymorphism of eNOS and BgI II polymorphism of ITGA2 genes and DR was observed, while there was no association between the genetic variants of those two polymorphisms and the type of retinopathy.
doi_str_mv 10.2147/TACG.S31979
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2222905226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2222905226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1066-3299212470f8cc1e77697334bf3cffebf2fd43bfc595b462287b8679a6a3bb463</originalsourceid><addsrcrecordid>eNpNkE1OwzAQhS0EElXpigtYYolS_JPE8bKqoCBVdNEisbMc125dtXGwXVBOwxk4A3vORNKwYBYzozefnjQPgGuMxgSn7G41mc7GS4o542dggDErEobS1_N_-yUYhbBDbaUI84wMwGESglNWRusqKCu5b4IN0Bm40ZWOVsF36fvrSdXPi2WLreHPF_n-xNBWUW-8rU54gB82bmFsag0JXFtZnhx82ytXy7htrsCFkfugR39zCF4e7lfTx2S-mD1NJ_NEYZTnCSWcE0xShkyhFNaM5ZxRmpaGKmN0aYhZp7Q0KuNZmeaEFKwscsZlLmnZCnQIbnrf2ru3ow5R7NzRt98FQdriKCOko257SnkXgtdG1N4epG8ERqKLVHSRij5S-guNzWpt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2222905226</pqid></control><display><type>article</type><title>Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy</title><source>Taylor &amp; Francis Open Access</source><source>DOVE Medical Press Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Ellakwa, Amin Faisal ; Azmy Elshazly ; Dawood, Abdelraouf ; Kelany Abdelhameed ; Abdelsatar Elghobashy ; Eldaly, mohammed</creator><creatorcontrib>Ellakwa, Amin Faisal ; Azmy Elshazly ; Dawood, Abdelraouf ; Kelany Abdelhameed ; Abdelsatar Elghobashy ; Eldaly, mohammed</creatorcontrib><description>Background: Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus. It has been suggested that nitric oxide (NO) and α2β1 integrin (a platelet receptor for collagen) play an important role in the pathogenesis of microvascular complications in DR. Aim: The aim of this study was to investigate the association of two candidate genes involved in the regulation of retinal vasculature, endothelial nitric oxide synthase (eNOS) and α2β1 integrin (ITGA2) genes, with the development of DR in Egyptian patients with type 2 diabetes mellitus and to investigate whether genetic variants will affect the type of retinopathy (proliferative or nonproliferative). Methods: In this study, 70 patients were enrolled and categorized into two groups: (1) a DR group consisting of 50 patients with DR, which was further subclassified into 25 patients with nonproliferative DR (NPDR group) and 25 patients with proliferative DR (PDR group) and (2) a diabetes without retinopathy (DWR) group, comprising 20 patients with type 2 diabetes of more than 10 years' duration who showed no signs of DR. Associations of the genetic polymorphisms of eNOS (G894T) and ITGA2 (BgI II) were studied. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed for all samples to evaluate the genotypes and correlate with the phenotype of the disease. Results: The allele frequencies of both polymorphisms showed considerable differences between patients with and without DR. The GG genotype of G894T polymorphism of eNOS was associated with a 9.75-fold increased risk of DR (95% confidence interval 1.7–55.4) and the genotype ITGA2 BgI II (+/+) was associated with a 10.1-fold increased risk of DR (95% confidence interval 1.8–57.9), while the α2β1 integrin gene polymorphism of genotype distribution of both eNOS and ITGA2 polymorphisms did not differ significantly between the proliferative and nonproliferative DR groups. Conclusion: A significant association between the G894T polymorphism of eNOS and BgI II polymorphism of ITGA2 genes and DR was observed, while there was no association between the genetic variants of those two polymorphisms and the type of retinopathy.</description><identifier>ISSN: 1178-704X</identifier><identifier>EISSN: 1178-704X</identifier><identifier>DOI: 10.2147/TACG.S31979</identifier><language>eng</language><publisher>Macclesfield: Taylor &amp; Francis Ltd</publisher><subject>Confidence intervals ; Diabetes ; Diabetic retinopathy ; Genotype &amp; phenotype ; Nitric oxide ; Polymorphism</subject><ispartof>Application of clinical genetics, 2012-07, Vol.5, p.55</ispartof><rights>2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1066-3299212470f8cc1e77697334bf3cffebf2fd43bfc595b462287b8679a6a3bb463</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,3849,27901,27902</link.rule.ids></links><search><creatorcontrib>Ellakwa, Amin Faisal</creatorcontrib><creatorcontrib>Azmy Elshazly</creatorcontrib><creatorcontrib>Dawood, Abdelraouf</creatorcontrib><creatorcontrib>Kelany Abdelhameed</creatorcontrib><creatorcontrib>Abdelsatar Elghobashy</creatorcontrib><creatorcontrib>Eldaly, mohammed</creatorcontrib><title>Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy</title><title>Application of clinical genetics</title><description>Background: Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus. It has been suggested that nitric oxide (NO) and α2β1 integrin (a platelet receptor for collagen) play an important role in the pathogenesis of microvascular complications in DR. Aim: The aim of this study was to investigate the association of two candidate genes involved in the regulation of retinal vasculature, endothelial nitric oxide synthase (eNOS) and α2β1 integrin (ITGA2) genes, with the development of DR in Egyptian patients with type 2 diabetes mellitus and to investigate whether genetic variants will affect the type of retinopathy (proliferative or nonproliferative). Methods: In this study, 70 patients were enrolled and categorized into two groups: (1) a DR group consisting of 50 patients with DR, which was further subclassified into 25 patients with nonproliferative DR (NPDR group) and 25 patients with proliferative DR (PDR group) and (2) a diabetes without retinopathy (DWR) group, comprising 20 patients with type 2 diabetes of more than 10 years' duration who showed no signs of DR. Associations of the genetic polymorphisms of eNOS (G894T) and ITGA2 (BgI II) were studied. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed for all samples to evaluate the genotypes and correlate with the phenotype of the disease. Results: The allele frequencies of both polymorphisms showed considerable differences between patients with and without DR. The GG genotype of G894T polymorphism of eNOS was associated with a 9.75-fold increased risk of DR (95% confidence interval 1.7–55.4) and the genotype ITGA2 BgI II (+/+) was associated with a 10.1-fold increased risk of DR (95% confidence interval 1.8–57.9), while the α2β1 integrin gene polymorphism of genotype distribution of both eNOS and ITGA2 polymorphisms did not differ significantly between the proliferative and nonproliferative DR groups. Conclusion: A significant association between the G894T polymorphism of eNOS and BgI II polymorphism of ITGA2 genes and DR was observed, while there was no association between the genetic variants of those two polymorphisms and the type of retinopathy.</description><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Diabetic retinopathy</subject><subject>Genotype &amp; phenotype</subject><subject>Nitric oxide</subject><subject>Polymorphism</subject><issn>1178-704X</issn><issn>1178-704X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpNkE1OwzAQhS0EElXpigtYYolS_JPE8bKqoCBVdNEisbMc125dtXGwXVBOwxk4A3vORNKwYBYzozefnjQPgGuMxgSn7G41mc7GS4o542dggDErEobS1_N_-yUYhbBDbaUI84wMwGESglNWRusqKCu5b4IN0Bm40ZWOVsF36fvrSdXPi2WLreHPF_n-xNBWUW-8rU54gB82bmFsag0JXFtZnhx82ytXy7htrsCFkfugR39zCF4e7lfTx2S-mD1NJ_NEYZTnCSWcE0xShkyhFNaM5ZxRmpaGKmN0aYhZp7Q0KuNZmeaEFKwscsZlLmnZCnQIbnrf2ru3ow5R7NzRt98FQdriKCOko257SnkXgtdG1N4epG8ERqKLVHSRij5S-guNzWpt</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Ellakwa, Amin Faisal</creator><creator>Azmy Elshazly</creator><creator>Dawood, Abdelraouf</creator><creator>Kelany Abdelhameed</creator><creator>Abdelsatar Elghobashy</creator><creator>Eldaly, mohammed</creator><general>Taylor &amp; Francis Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201207</creationdate><title>Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy</title><author>Ellakwa, Amin Faisal ; Azmy Elshazly ; Dawood, Abdelraouf ; Kelany Abdelhameed ; Abdelsatar Elghobashy ; Eldaly, mohammed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1066-3299212470f8cc1e77697334bf3cffebf2fd43bfc595b462287b8679a6a3bb463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Diabetic retinopathy</topic><topic>Genotype &amp; phenotype</topic><topic>Nitric oxide</topic><topic>Polymorphism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ellakwa, Amin Faisal</creatorcontrib><creatorcontrib>Azmy Elshazly</creatorcontrib><creatorcontrib>Dawood, Abdelraouf</creatorcontrib><creatorcontrib>Kelany Abdelhameed</creatorcontrib><creatorcontrib>Abdelsatar Elghobashy</creatorcontrib><creatorcontrib>Eldaly, mohammed</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Application of clinical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ellakwa, Amin Faisal</au><au>Azmy Elshazly</au><au>Dawood, Abdelraouf</au><au>Kelany Abdelhameed</au><au>Abdelsatar Elghobashy</au><au>Eldaly, mohammed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy</atitle><jtitle>Application of clinical genetics</jtitle><date>2012-07</date><risdate>2012</risdate><volume>5</volume><spage>55</spage><pages>55-</pages><issn>1178-704X</issn><eissn>1178-704X</eissn><abstract>Background: Diabetic retinopathy (DR) is classically defined as a microvasculopathy that primarily affects the small blood vessels of the inner retina as a complication of diabetes mellitus. It has been suggested that nitric oxide (NO) and α2β1 integrin (a platelet receptor for collagen) play an important role in the pathogenesis of microvascular complications in DR. Aim: The aim of this study was to investigate the association of two candidate genes involved in the regulation of retinal vasculature, endothelial nitric oxide synthase (eNOS) and α2β1 integrin (ITGA2) genes, with the development of DR in Egyptian patients with type 2 diabetes mellitus and to investigate whether genetic variants will affect the type of retinopathy (proliferative or nonproliferative). Methods: In this study, 70 patients were enrolled and categorized into two groups: (1) a DR group consisting of 50 patients with DR, which was further subclassified into 25 patients with nonproliferative DR (NPDR group) and 25 patients with proliferative DR (PDR group) and (2) a diabetes without retinopathy (DWR) group, comprising 20 patients with type 2 diabetes of more than 10 years' duration who showed no signs of DR. Associations of the genetic polymorphisms of eNOS (G894T) and ITGA2 (BgI II) were studied. Polymerase chain reaction-restriction fragment length polymorphism analysis was performed for all samples to evaluate the genotypes and correlate with the phenotype of the disease. Results: The allele frequencies of both polymorphisms showed considerable differences between patients with and without DR. The GG genotype of G894T polymorphism of eNOS was associated with a 9.75-fold increased risk of DR (95% confidence interval 1.7–55.4) and the genotype ITGA2 BgI II (+/+) was associated with a 10.1-fold increased risk of DR (95% confidence interval 1.8–57.9), while the α2β1 integrin gene polymorphism of genotype distribution of both eNOS and ITGA2 polymorphisms did not differ significantly between the proliferative and nonproliferative DR groups. Conclusion: A significant association between the G894T polymorphism of eNOS and BgI II polymorphism of ITGA2 genes and DR was observed, while there was no association between the genetic variants of those two polymorphisms and the type of retinopathy.</abstract><cop>Macclesfield</cop><pub>Taylor &amp; Francis Ltd</pub><doi>10.2147/TACG.S31979</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-704X
ispartof Application of clinical genetics, 2012-07, Vol.5, p.55
issn 1178-704X
1178-704X
language eng
recordid cdi_proquest_journals_2222905226
source Taylor & Francis Open Access; DOVE Medical Press Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Confidence intervals
Diabetes
Diabetic retinopathy
Genotype & phenotype
Nitric oxide
Polymorphism
title Association analysis of genetic variations of eNOS and α2ß1 integrin genes with type 2 diabetic retinopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T15%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20analysis%20of%20genetic%20variations%20of%20eNOS%20and%20%CE%B12%C3%9F1%20integrin%20genes%20with%20type%202%20diabetic%20retinopathy&rft.jtitle=Application%20of%20clinical%20genetics&rft.au=Ellakwa,%20Amin%20Faisal&rft.date=2012-07&rft.volume=5&rft.spage=55&rft.pages=55-&rft.issn=1178-704X&rft.eissn=1178-704X&rft_id=info:doi/10.2147/TACG.S31979&rft_dat=%3Cproquest_cross%3E2222905226%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2222905226&rft_id=info:pmid/&rfr_iscdi=true